Henling C E, Slogoff S, Kodali S V, Arlund C
Anesth Analg. 1984 May;63(5):515-20.
We evaluated risk of heart block after cardiopulmonary by-pass (CPB) in patients with normal conduction undergoing coronary artery bypass grafting who chronically received calcium-entry blockers, beta-blockers, or combined therapy. Before CPB, calcium-entry blockers alone produced an increase in P-R intervals but no change in heart rate; calcium-entry blocker effects were undetectable after CPB, beta-Blockers alone or with calcium-entry blockers produced lower heart rates and longer P-R intervals throughout the entire perioperative period when compared to no therapy (control) or calcium-entry blockers alone. Complete heart block did not occur; one control patient had transient second degree block after CPB. First degree block appeared transiently in 5% of the patients after anesthetic induction and in 15% on emergence from CPB, but was unrelated to drug therapy. We conclude that chronic calcium-entry blocker therapy has minimal effects on conduction perioperatively; beta-blocker effects persist for up to 10 hr after CPB; and the risk of heart block with either drug or combination is low and should not be a factor in their continued administration preoperatively.
我们评估了长期接受钙通道阻滞剂、β受体阻滞剂或联合治疗的冠状动脉搭桥术患者在体外循环(CPB)后发生心脏传导阻滞的风险,这些患者术前传导功能正常。在CPB前,单独使用钙通道阻滞剂会使P-R间期延长,但心率无变化;CPB后未检测到钙通道阻滞剂的作用,与未治疗(对照)或单独使用钙通道阻滞剂相比,单独使用β受体阻滞剂或与钙通道阻滞剂联合使用在整个围手术期会使心率降低,P-R间期延长。未发生完全性心脏传导阻滞;1例对照患者在CPB后出现短暂性二度阻滞。一度阻滞在麻醉诱导后5%的患者中短暂出现,在CPB结束时15%的患者中出现,但与药物治疗无关。我们得出结论,围手术期长期使用钙通道阻滞剂对传导功能影响极小;CPB后β受体阻滞剂的作用可持续长达10小时;单独使用或联合使用这两种药物发生心脏传导阻滞的风险较低,不应成为术前继续用药的影响因素。